Novo Nordisk Submits BLA for Mim8, Offering Flexible Hemophilia A Prophylaxis
Bagsværd, Denmark & Plainsboro, N.J., September 29, 2025 – Novo Nordisk has formally submitted a Biologics License Application (BLA)...
Advertisement
Merck Reports Positive HYPERION Results for Pulmonary Hypertension Therapy
RAHWAY, N.J., Sept. 30, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today...
FDA Approves ZOLL Zenix Defibrillator to Advance Cardiac Care
CHELMSFORD, Mass., Sept. 30, 2025 — The U.S. Food and Drug Administration (FDA) has approved the ZOLL Zenix Monitor/Defibrillator,...
Star Therapeutics Raises $125M to Advance Bleeding Disorder Therapy
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2025 — Star Therapeutics announced it has closed an oversubscribed $125 million Series...
Neuropixels Tech Enables New Brain Insights in Parkinson’s Study
AURORA, Colo., Sept. 30, 2025 — Researchers at the University of Colorado Anschutz Medical Campus announced the first FDA-authorized...
FDA Fast Track Granted to CS-1103 for Meth Intoxication
CAMBRIDGE, Mass., Sept. 30, 2025 — Clear Scientific, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves TREMFYA® for Pediatric Psoriasis and Psoriatic Arthritis
Horsham, Pa., Sept. 29, 2025 – The U.S. Food and Drug Administration (FDA) has granted approval for TREMFYA® (guselkumab)...
FDA Approves Biosimilar Denosumab Expanding U.S. Patient Access
Budapest / London, September 29, 2025 Gedeon Richter and Hikma announced that the U.S. Food and Drug Administration (FDA)...
Oncolytics Prepares Registration Trial in First-Line Pancreatic Cancer
SAN DIEGO, Sept. 29, 2025 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) today announced a key update on its plan...
Larimar’s Nomlabofusp Shows Long-Term Promise in Friedreich’s Ataxia
Bala Cynwyd, Pa., September 29, 2025: Larimar Therapeutics announced positive new data from an ongoing long-term open-label study of...
Advertisement
